A study conducted by Uher et al. (2014) found that patients with CRP < 1mgI-1 showed a greater symptomatic improvement in depression with escitalopram than with Nortriptyline, while those with CRP >1 showed greater improvement with nortriptyline rather than with escitalopram. This evidence concerns the gene CRP and depressive disorder.